Novo Nordisk cuts 2025 outlook as Wegovy obesity drug sales slow

Novo Nordisk cuts 2025 outlook as Wegovy obesity drug sales slow#Novo #Nordisk #cuts #outlook #Wegovy #obesity #drug #sales #slow